Dr. Cameron Clokie has over 20 patents both in the United States and abroad for innovations in the field of musculoskeletal reconstruction and regeneration. Among those innovations is a procedure that regrew a section of a patient’s jaw bone. His practice Induce Biologics Inc. specializes in musculoskeletal regeneration.
Dr. Clokie holds both a Doctor of Dental Surgery (DDS) degree and a Ph.D. from McGill University. Over the last three decades, he has added entrepreneur, educator, international lecturer, author, scientific advisor and Toronto University’s head of Oral and Maxillofacial Surgery to his résumé.
Regenerative medicine as defined by Dr. Cameron Clokie employs stem cells, biomaterials, and molecules in the repair of the physical damage done by illness or injury. Blood transfusions and bone marrow transplants are both stem cell therapies. A burn patient’s own cells can be used to grow new skin over the area of the burn. The three aforementioned forms of cell therapy have paved the way for Dr. Clokie’s breakthroughs.
Very few patients ever benefit from new developments in regenerative therapy. Patients that have the financial wherewithal to do so turn to private hospitals. These facilities often render unproven therapies that ascorbate the patient’s condition.
There are three issues that keep regenerative treatments from being more readily available. Even though they can prolong and improve quality of life regenerative medicine is not universally accepted within the medical community.
Despite the likelihood of reducing medical costs in the long-term regenerative medicine is hamstrung by the hobgoblin of all progress; cost. Requiring specialized facilities, staff with unique skill sets and high production costs regenerative procedures are currently more expensive than traditional treatment options.
Lastly, the number of regenerative treatments approved by the Food and Drug Administration is extremely low.
Even with the obstacles mentioned above research in regenerative medicine is being conducted around the world. Most recently, a chip was developed that makes organ repair possible by causing cells to change their intended function.
As with any medical treatment, regenerative therapies have their drawbacks. Favorable results are not guaranteed. Even when successful initially that success can reverse itself over time.